BI 730357 Psoriasis Long Term Extension
Research payments
$1,327,948
Through program year 2022, $1,327,948 in research payments was reported against BI 730357 Psoriasis Long Term Extension, across 93 payments, paid by Boehringer Ingelheim Pharmaceuticals, Inc..
- Paid by
- Boehringer Ingelheim Pharmaceuticals, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $127,455 | 13 |
| 2021 | Research | $582,499 | 33 |
| 2020 | Research | $403,226 | 29 |
| 2019 | Research | $214,769 | 18 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Tiffani Hamilton Alpharetta, GA Named on 7 payments
- James Krell Birmingham, AL Named on 7 payments
- David Pariser Norfolk, VA Named on 7 payments
- Richard Beasley Rapid City, SD Named on 6 payments
- Stephen Tyring Webster, TX Named on 6 payments
- Todd Schlesinger Charleston, SC Named on 5 payments
- Alice Gottlieb New York, NY Named on 5 payments
- Jennifer Soung Santa Ana, CA Named on 5 payments
- Martin Menter Dallas, TX Named on 5 payments
- Patricia Lee Webster, TX Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.